Equity markets performed well in January, as they often do, but as the dust settles on that early-year run, the strategy for long-term investors remains the same: Invest in companies that can perform ...

Learn more about whether Amicus Therapeutics, Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, ...

Houston-based Moleculin Biotech, Inc., currently trading at $0.80 and showing a market capitalization of $2.4 million, has entered into an agreement with an investor to modify certain terms of ...

Discover why income-focused investors are eyeing HQH with its high dividend yield and discounted NAV, despite sector-specific ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

Biotech firm Phytome Life Sciences plans to establish a headquarters in Saudi Arabia in a bid to accelerate commercialization ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Buy rating on BioNTech SE (BNTX – Research Report), with a price ...

Riding on Rohit Sharma's 119, India chased down England's 304 with 33 balls to spare and four wickets in hand. India thus win ...

Nikkei 225 index is a price-weighted average index, and its components are reviewed once a year. The Nikkei225 index is the most widely quoted average of Japanese stocks. Topix is considered to be ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...